RankingsPricing
  1. JP-listed companies
  2. Delta-Fly Pharma, Inc.
  3. Financials
  4. Operating income

Delta-Fly Pharma, Inc.【JP:4598】

Market cap
¥4.9B
P/E ratio
-2.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 2025-1,708+21.71%
Mar 31, 2024-1,403+6.66%
Mar 31, 2023-1,316+36.86%
Mar 31, 2022-961+12.82%
Mar 31, 2021-852-44.86%
Mar 31, 2020-1,546+160.84%
Mar 31, 2019-593+143.02%
Mar 31, 2018-244

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)